CEUTIX PHARMACEUTICALS LIMITED
45 ST. HELENS GROVE, MONKSTON, MILTON KEYNES  MK10 9FG- Active - Proposal to Strike off
- Private Limited Company
- Company No. 14289432
- Last Updated: 01 Jan 2024
Company Profile
CEUTIX PHARMACEUTICALS LIMITED was incorporated on Wednesday, August 10, 2022 as a Private Limited Company with registered address in MILTON KEYNES. CEUTIX PHARMACEUTICALS LIMITED has the status: Active - Proposal to Strike off and it's listed in the following category: Wholesale of pharmaceutical goods. This Private Limited Company has been operating for 2 years 6 months and 14 days.
Name | CEUTIX PHARMACEUTICALS LIMITED |
---|---|
Company number | 14289432 |
Company type | Private Limited Company |
Incorporation date | 10 Aug 2022 |
Status | Active - Proposal to Strike off |
Industry (SIC 2007) |
Address
Registered Address |
45 ST. HELENS GROVE MONKSTON MILTON KEYNES MK10 9FG |
---|---|
Country Of Origin | ENGLAND |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Mrs Adwoa Akoma Achamfour Nationality: British |
Dates: Wednesday, August 10, 2022 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
right to appoint and remove directors
|
Mr Alex Achamfour Nationality: Ghanaian |
Dates: Wednesday, August 10, 2022 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
right to appoint and remove directors
|
Accounts and Confirmation
Type of accounts | NO ACCOUNTS FILED |
---|---|
End of financial Year | 31 August |
Next annual accounts due | 10 May 2024, (-290 days left) |
Latest accounts | Not available |
Next confirmation statement due | 07 September 2023 |
Last confirmation statement dated | Not available |
Mortgages
No mortgages have been registered against CEUTIX PHARMACEUTICALS LIMITED.
Previous Names
Name | Change Date |
---|---|
CEUTIX PHARMACEUTICALS LIMITED | 10 Aug 2022 |